SCHEMBL22149692

SCHEMBL22149692

C=CC(=O)N1CC(C(=O)N2CCN(c3ccc(-c4cnc5ccc(Nc6cc(OC)cc(OC)c6)cc5n4)cn3)CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 2/20 0.50
KDR P35968 2/20 0.50
EGFR P00533 7/20 0.43
BTK Q06187 5/20 0.43
HPGD P15428 4/20 0.41
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
JAK3 P52333 2/20 0.40
ITK Q08881 3/20 0.39
KRAS P01116 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31655616 1.00 FGFR3 (0.50) FGFR3KDREGFRBTKHPGD
SCHEMBL31655645 0.89 FGFR3 (0.46) FGFR3KDREGFRBTKHPGD
SCHEMBL22149694 0.89 FGFR3 (0.46) FGFR3KDREGFRBTKHPGD
SCHEMBL22149351 0.88 FGFR3 (0.49) FGFR3KDREGFRBTKFGFR1
SCHEMBL31655614 0.88 FGFR3 (0.49) FGFR3KDREGFRBTKFGFR1
SCHEMBL22149693 0.86 FGFR3 (0.48) FGFR3KDREGFRBTKHPGD
SCHEMBL31655631 0.86 FGFR3 (0.48) FGFR3KDREGFRBTKHPGD
SCHEMBL22122045 0.84 FGFR3 (0.55) FGFR3KDRFGFR1FGFR2FGFR4
SCHEMBL22149125 0.83 FGFR3 (0.58) FGFR3KDRFGFR1FGFR2FGFR4
SCHEMBL31655653 0.83 FGFR3 (0.58) FGFR3KDRFGFR1FGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020131674-A1 7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER ARRAY BIOPHARMA INC. (US) 2020-06-25 WO disclosed